Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Porras

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Journal of Clinical Pharmacology|October 5, 2002
Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjectsCynthia A Guzzo, Christine I Furtek, Arturo G Porras, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|November 27, 1998
Splenectomy complications in hematological diseasesG J Ruiz-Argüelles, B M Velázquez, R Pérez-Tamayo, et al.
Clinical Pharmacology and Therapeutics|November 5, 1999
Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsJ D Rogers, J Zhao, L Liu, et al.
Developmental Psychobiology|May 13, 2024
Role of tactile stimulation during the preweaning period on the development of the peripheral sensory sural (SU) nerve in adult artificially reared female ratAngel I Melo, Rene Zempoalteca, Gabriela Ramirez-Funez, et al.
Clinical Drug Investigation|May 31, 2007
Pharmacokinetic evaluation of rofecoxib : comparison of tablet and suspension formulationsJules I Schwartz, Patrick J Larson, Arturo G Porras, et al.
Clinical Therapeutics|October 4, 2011
Bioavailability and short-term tolerability of alendronate in glucocorticoid-treated childrenMeranda Nakhla, Andrew E Denker, James D Connor, et al.
Journal of Clinical Pharmacology|April 10, 1999
Pharmacokinetics of intravenous alendronateV Cocquyt, W F Kline, B J Gertz, et al.
Journal of Clinical Pharmacology|October 5, 2001
Lack of pharmacokinetic interaction between rofecoxib and methotrexate in rheumatoid arthritis patientsJ I Schwartz, N G Agrawal, P H Wong, et al.
Developmental Neurobiology|December 3, 2017
Early postnatal development of electrophysiological and histological properties of sensory sural nerves in male rats that were maternally deprived and artificially reared: Role of tactile stimulationRene Zempoalteca, Mercedes G Porras, Suelem Moreno-Pérez, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2002
The disposition and metabolism of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in human subjectsRita A Halpin, Arturo G Porras, Leslie A Geer, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Journal of Clinical Pharmacology|October 5, 2002
Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjectsCynthia A Guzzo, Christine I Furtek, Arturo G Porras, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|November 27, 1998
Splenectomy complications in hematological diseasesG J Ruiz-Argüelles, B M Velázquez, R Pérez-Tamayo, et al.
Clinical Pharmacology and Therapeutics|November 5, 1999
Grapefruit juice has minimal effects on plasma concentrations of lovastatin-derived 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitorsJ D Rogers, J Zhao, L Liu, et al.
Developmental Psychobiology|May 13, 2024
Role of tactile stimulation during the preweaning period on the development of the peripheral sensory sural (SU) nerve in adult artificially reared female ratAngel I Melo, Rene Zempoalteca, Gabriela Ramirez-Funez, et al.
Clinical Drug Investigation|May 31, 2007
Pharmacokinetic evaluation of rofecoxib : comparison of tablet and suspension formulationsJules I Schwartz, Patrick J Larson, Arturo G Porras, et al.
Clinical Therapeutics|October 4, 2011
Bioavailability and short-term tolerability of alendronate in glucocorticoid-treated childrenMeranda Nakhla, Andrew E Denker, James D Connor, et al.
Journal of Clinical Pharmacology|April 10, 1999
Pharmacokinetics of intravenous alendronateV Cocquyt, W F Kline, B J Gertz, et al.
Journal of Clinical Pharmacology|October 5, 2001
Lack of pharmacokinetic interaction between rofecoxib and methotrexate in rheumatoid arthritis patientsJ I Schwartz, N G Agrawal, P H Wong, et al.
Developmental Neurobiology|December 3, 2017
Early postnatal development of electrophysiological and histological properties of sensory sural nerves in male rats that were maternally deprived and artificially reared: Role of tactile stimulationRene Zempoalteca, Mercedes G Porras, Suelem Moreno-Pérez, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 23, 2002
The disposition and metabolism of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in human subjectsRita A Halpin, Arturo G Porras, Leslie A Geer, et al.
Pageof 8